Prelude Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Sell |
143,129
-49,078
| -26% | -$338K | 0.1% | 263 |
|
|
2025
Q1 | $554K | Buy |
192,207
+106,122
| +123% | +$306K | 0.04% | 408 |
|
|
2024
Q4 | $405K | Buy |
86,085
+62,985
| +273% | +$296K | 0.03% | 572 |
|
|
2024
Q3 | $82.5K | Sell |
23,100
-5,000
| -18% | -$17.9K | 0.01% | 1072 |
|
|
2024
Q2 | $174K | Buy |
+28,100
| New | +$174K | 0.01% | 937 |
|
|
2023
Q3 | – | Sell |
-11,171
| Closed | -$36.9K | – | 1070 |
|
|
2023
Q2 | $36.9K | Buy |
+11,171
| New | +$36.9K | ﹤0.01% | 872 |
|
|
2020
Q3 | – | Sell |
-6,073
| Closed | -$111K | – | 1545 |
|
|
2020
Q2 | $111K | Buy |
+6,073
| New | +$111K | 0.01% | 631 |
|